114 related articles for article (PubMed ID: 38193945)
21. Immunoexpression of Epithelial Mesenchymal Transition Proteins E-Cadherin, β-Catenin, and N-Cadherin in Oral Squamous Cell Carcinoma.
Angadi PV; Patil PV; Angadi V; Mane D; Shekar S; Hallikerimath S; Kale AD; Kardesai SG
Int J Surg Pathol; 2016 Dec; 24(8):696-703. PubMed ID: 27312520
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical evaluation of E-cadherin in oral epithelial dysplasia and squamous cell carcinoma.
Sharma J; Bhargava M; Aggarwal S; Aggarwal A; Varshney A; Chopra D
Indian J Pathol Microbiol; 2022; 65(4):755-760. PubMed ID: 36308176
[TBL] [Abstract][Full Text] [Related]
23. p63 and E-cadherin Expression in Canine Oral Squamous Cell Carcinoma.
Mestrinho LA; Pissarra H; Faísca PB; Bragança M; Peleteiro MC; Niza MM
Vet Pathol; 2015 Jul; 52(4):614-20. PubMed ID: 25248518
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-625-3p promotes cell migration of oral squamous cell carcinoma by regulating SCAI expression.
Xu D; Gu M; Liu HL
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):641-648. PubMed ID: 30720172
[TBL] [Abstract][Full Text] [Related]
25. CDH4 inhibits ferroptosis in oral squamous cell carcinoma cells.
Xie J; Lan T; Zheng DL; Ding LC; Lu YG
BMC Oral Health; 2023 May; 23(1):329. PubMed ID: 37237299
[TBL] [Abstract][Full Text] [Related]
26. The expression of calretinin and cytokeratins in canine acanthomatous ameloblastoma and oral squamous cell carcinoma.
Fulton A; Arzi B; Murphy B; Naydan DK; Verstraete FJ
Vet Comp Oncol; 2014 Dec; 12(4):258-65. PubMed ID: 22985095
[TBL] [Abstract][Full Text] [Related]
27. CD147 promotes proliferation and migration of oral cancer cells by inhibiting junctions between E-cadherin and β-catenin.
Min A; Xiong H; Wang W; Hu X; Wang C; Mao T; Yang L; Huang D; Xia K; Su T
J Oral Pathol Med; 2020 Nov; 49(10):1019-1029. PubMed ID: 32740991
[TBL] [Abstract][Full Text] [Related]
28. Comparative E-Cadherin Digital Expression Analysis in HPV and non-HPV Related Squamous Cell Carcinoma of the Oral Cavity.
Chrysovergis A; Papanikolaou V; Mastronikolis N; Spyropoulou D; Adamopoulou M; Tsiambas E; Peschos D; Ragos V; Kyrodimos E
Anticancer Res; 2021 Jan; 41(1):163-167. PubMed ID: 33419809
[TBL] [Abstract][Full Text] [Related]
29. A novel MCT1 and MCT4 dual inhibitor reduces mitochondrial metabolism and inhibits tumour growth of feline oral squamous cell carcinoma.
Khammanivong A; Saha J; Spartz AK; Sorenson BS; Bush AG; Korpela DM; Gopalakrishnan R; Jonnalagadda S; Mereddy VR; O'Brien TD; Drewes LR; Dickerson EB
Vet Comp Oncol; 2020 Sep; 18(3):324-341. PubMed ID: 31661586
[TBL] [Abstract][Full Text] [Related]
30. Functional analysis of the miR-145/Fascin1 cascade in canine oral squamous cell carcinoma.
Noguchi S; Tanimoto N; Nishida R; Matsui A
Oral Dis; 2023 May; 29(4):1495-1504. PubMed ID: 35103365
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of Her-2 protein in histologically tumor-free margins of oral squamous cell carcinoma: An immunohistochemical study.
Kamat M; Puranik RS; Rai BD; Patil BR; Varsha VK; Kamat S
J Cancer Res Ther; 2023 Apr; 19(Supplement):S417-S421. PubMed ID: 37148009
[TBL] [Abstract][Full Text] [Related]
32. Molecular and immunohistochemical studies do not support a role for papillomaviruses in canine oral squamous cell carcinoma development.
Munday JS; French A; Harvey CJ
Vet J; 2015 May; 204(2):223-5. PubMed ID: 25956344
[TBL] [Abstract][Full Text] [Related]
33. Relationship between SDC1 and cadherin signalling activation in cancer.
Liao S; Liu C; Zhu G; Wang K; Yang Y; Wang C
Pathol Res Pract; 2020 Jan; 216(1):152756. PubMed ID: 31810587
[TBL] [Abstract][Full Text] [Related]
34. Ki67 Labelling Index of Neoplastic Epithelial Cells Differentiates Canine Acanthomatous Ameloblastoma from Oral Squamous Cell Carcinoma.
Peralta S; Grenier JK; McCleary-Wheeler AL; Duhamel GE
J Comp Pathol; 2019 Aug; 171():59-69. PubMed ID: 31540626
[TBL] [Abstract][Full Text] [Related]
35. Changed expression of E-cadherin and galectin-9 in oral squamous cell carcinomas but lack of potential as prognostic markers.
Chan SW; Kallarakkal TG; Abraham MT
Asian Pac J Cancer Prev; 2014; 15(5):2145-52. PubMed ID: 24716948
[TBL] [Abstract][Full Text] [Related]
36. E-Cadherin and Syndecan-1 Expression in Patients With Advanced Non-small Cell Lung Cancer Treated With Chemoradiotherapy.
Gkogkou P; Peponi E; Ntaskagiannis D; Murray S; Demou A; Sainis I; Ioakeim E; Briasoulis E; Tsekeris P
In Vivo; 2020; 34(1):453-459. PubMed ID: 31882513
[TBL] [Abstract][Full Text] [Related]
37. E-cadherin downregulation and Twist overexpression since early stages of oral carcinogenesis.
de Freitas Silva BS; Yamamoto-Silva FP; Pontes HA; Pinto Júnior Ddos S
J Oral Pathol Med; 2014 Feb; 43(2):125-31. PubMed ID: 23772858
[TBL] [Abstract][Full Text] [Related]
38. Detection of canine oral papillomavirus-DNA in canine oral squamous cell carcinomas and p53 overexpressing skin papillomas of the dog using the polymerase chain reaction and non-radioactive in situ hybridization.
Teifke JP; Löhr CV; Shirasawa H
Vet Microbiol; 1998 Feb; 60(2-4):119-30. PubMed ID: 9646444
[TBL] [Abstract][Full Text] [Related]
39. Expression of E-cadherin and vimentin in oral squamous cell carcinoma.
Zhou J; Tao D; Xu Q; Gao Z; Tang D
Int J Clin Exp Pathol; 2015; 8(3):3150-4. PubMed ID: 26045832
[TBL] [Abstract][Full Text] [Related]
40. Alteration in E-cadherin/β-catenin expression in canine melanotic tumors.
Han JI; Kim Y; Kim DY; Na KJ
Vet Pathol; 2013 Mar; 50(2):274-80. PubMed ID: 22895538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
